Are you actually serious ? If/when we start a phase 2 for TBI etc, dosage rates and delivery methods below have been proven safe already. Do you expect we do another phase 1 that is 100% identical to the first phase 1 trial ?
The aim of this pilot study was to investigate whether ARG-007, delivered intravenously at
either a 100 nmol/kg or 300 nmol/kg dose, can improve motor and cognitive outcome with
an associated reduction in axonal injury and neuroinflammation at 3 days following a mildmoderate diffuse head injury in ferrets. The animals were randomly allocated via a random
number generator to sham (uninjured) (n = 9) or injury (n = 25), with injured ferrets
administered either vehicle (saline; n = 10), 100nmol/kg (0.3 mg/kg) R18D (n =8) or
300nmol/kg (0.9 mg/kg) R18D (n = 7).
I'm thinking you are trying to get some cheap shares with a bit of misinformation ... good luck
- Forums
- ASX - By Stock
- AGN Media thread
Are you actually serious ? If/when we start a phase 2 for TBI...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
84.5¢ |
Change
0.035(4.32%) |
Mkt cap ! $108.0M |
Open | High | Low | Value | Volume |
82.5¢ | 86.5¢ | 81.0¢ | $174.1K | 207.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11063 | 83.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
84.5¢ | 16050 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 11063 | 0.830 |
1 | 11764 | 0.825 |
1 | 10000 | 0.820 |
1 | 5005 | 0.815 |
2 | 13338 | 0.795 |
Price($) | Vol. | No. |
---|---|---|
0.845 | 16050 | 2 |
0.850 | 15110 | 2 |
0.855 | 4400 | 1 |
0.860 | 463 | 1 |
0.865 | 31981 | 1 |
Last trade - 14.26pm 12/08/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |